Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAF1 | P04049 | 12/20 | 0.49 |
| ▸ | BRAF | P15056 | 11/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | IDH2 | P48735 | 4/20 | 0.48 |
| ▸ | AKT1 | P31749 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | STAT3 | P40763 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14783483 | 1.00 | RAF1 (0.49) | RAF1BRAFEPHX2IDH2AKT1 | |
| SCHEMBL15688893 | 0.94 | RAF1 (0.49) | RAF1BRAFEPHX2IDH2AKT1 | |
| SCHEMBL29590262 | 0.93 | EPHX2 (0.57) | BRAFEPHX2MAPTSTAT3SMN1; SMN2 | |
| SCHEMBL14783088 | 0.93 | EPHX2 (0.57) | BRAFEPHX2MAPTSTAT3SMN1; SMN2 | |
| SCHEMBL14783329 | 0.92 | RAF1 (0.48) | RAF1BRAFEPHX2IDH2AKT1 | |
| SCHEMBL29590266 | 0.92 | RAF1 (0.48) | RAF1BRAFEPHX2IDH2AKT1 | |
| SCHEMBL16786677 | 0.92 | MEN1 (0.45) | BRAFMAPT | |
| SCHEMBL29590980 | 0.92 | RAF1 (0.57) | RAF1BRAF | |
| SCHEMBL14783381 | 0.92 | RAF1 (0.57) | RAF1BRAF | |
| SCHEMBL15689339 | 0.91 | RAF1 (0.52) | RAF1BRAFEPHX2IDH2AKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115403531-A | Chemical entities, compositions, and methods as kinase inhibitors | 润新生物公司 | 2022-11-29 | — | — | CN | disclosed |
| CN-108794411-B | Certain chemical entities, compositions, and methods | 润新生物公司 | 2022-06-07 | — | — | CN | disclosed |